BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7775622)

  • 1. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
    Larsson H; Berglund G; Ahrén B
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetologia; 1996 Sep; 39(9):1099-107. PubMed ID: 8877295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B; Larsson H; Holst JJ
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
    Larsson H; Ahrén B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine.
    Larsson H; Ahrén B
    Diabetologia; 1998 Jul; 41(7):772-7. PubMed ID: 9686917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet dysfunction in obese women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Metabolism; 1996 Apr; 45(4):502-9. PubMed ID: 8609839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon secretion in relation to insulin sensitivity in healthy subjects.
    Ahrén B
    Diabetologia; 2006 Jan; 49(1):117-22. PubMed ID: 16362283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.
    Ahrén B
    Diabetes; 2009 Mar; 58(3):726-31. PubMed ID: 19095762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
    Ahrén B; Pacini G
    Am J Physiol; 1997 Oct; 273(4):E701-7. PubMed ID: 9357798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women.
    Larsson H; Ahrén B
    Diabetologia; 2000 Feb; 43(2):194-202. PubMed ID: 10753041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls.
    Roy A; Kamalanathan S; Sahoo J; Kar SS; Naik D; Narayanan N; Merugu C; Patel D
    Diabetes Res Clin Pract; 2021 Jun; 176():108846. PubMed ID: 33951481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.